pancreatic
alpha
beta
cell
function
cystic
fibrosis
insulin
glucagon
secretion
studied
oral
glucose
tolerance
testing
arginine
infusion
patient
cystic
fibrosis
two
group
patient
identified
group
n
whose
ogtt
entirely
normal
group
ii
n
abnormality
glucose
ogtt
group
basal
glucagon
concentration
normal
supressed
appropriately
p
le
glucose
insulin
response
attenuated
peak
response
delayed
arginine
stimulation
insulin
secretion
impaired
group
however
glucagon
secretion
diminished
group
ii
thus
insulinopenia
found
group
hyperglucagonemia
found
contributory
factor
hyperglycemia
group
ii
